LA Times Article is a Cheap Hit Piece that Insults Millions Around the World

LA Times Article is a Cheap Hit Piece that Insults Millions Around the World

Los Angeles Times (LA Times) journalist Michael Hiltzik is the latest hired gun in the mainstream media to line up and take a pop-shot at the drug, Ivermectin. Running with a reductive and anti-intellectual dig (Ivermectin is the new Hydroxychloroquine), Mr. Hiltzik declares that while the anti-malarial drug isn’t discussed much nowadays, Ivermectin is, and he believes it shouldn’t be due to “an utter lack of scientific evidence.” For him to use the words ``utter lack” can only mean that he hasn’t actually looked at the current evidence base or lacks the scientific shrewdness to accurately assess it. Surely, even the National Institutes of Health (NIH) COVID-19 Treatment Guidelines Panel would disagree with his choice of words, considering they changed their August 2020 stance from recommending against Ivermectin for COVID-19 to not being able to recommend for or against it in January of 2021, after listening to evidence presented by Dr. Paul Marik, Dr. Pierre Kory and epidemiologist and WHO consultant Dr. Andrew Hill. 

While vaccines are now available, in rich countries that is, they are not enough to end the global pandemic. This is why the NIH is putting billions of dollars ...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee